Therapies

Australian researchers have featured prominently in research efforts that have determined no genetic link between myopia and primary open-angle glaucoma...

Australian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye. Cequa (ciclosporin 900 microgram/mL)...

Novartis is working to ensure its newly-approved drug Beovu is accessible via the Pharmaceutical Benefits Scheme (PBS) at the earliest...

A new approach that uses an algorithm to analyse retinal images could help practitioners select the best treatment for patients...

Prednefrin Forte eye drops can now be prescribed to Aboriginal and Torres Strait Islander patients under the Pharmaceutical Benefits Scheme...

Australia’s first myopia management survey has revealed single‐vision distance spectacles are the mainstay of myopia correction in school‐aged children, despite...

A meta-analysis of scientific studies evaluating Zeiss’ At Lisa tri family intraocular lenses (IOL) has offered new insight into its...

A world-first clinical trial in Australia is investigating whether vitamin B3 could help protect nerve cells against damage in glaucoma....

In a finding that may have significant implications for how glaucoma is diagnosed and managed, researchers from the University of...

Scientists have developed an injectable biosynthetic ‘glue filler’ that repairs corneal perforations, potentially removing the need for corneal donations and...